Unlocking the Power of the Genome
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Illumina | Sequencing and array-based solutions for genetic research
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Juno Bio healthtech, Biotechnology Research | Not capitalistic Not partnership Event 30 Nov 2021 | | ||
Singapore Cancer Society healthtech, Non-profit Organizations | Other 31 May 2022 | | ||
Allelica, Inc biotech, deeptech, Biotechnology Research | Other 8 Jul 2022 | | ||
Autorité de la concurrence Government Administration | Other 14 Jul 2022 | | ||
Family Giving Tree edtech, Individual and Family Services | Other 26 Jul 2022 | | ||
The Montgomery Summit Software Development | Other 31 Aug 2022 | | ||
Lygature deeptech, healthtech, Non-profit Organizations | Other 18 Sep 2022 | | ||
International Wheat Genome Sequencing Consortium entertainment, Research Services | Other 30 Sep 2022 | | ||
Trecento AM Financial Services | Other 13 Oct 2022 | | ||
ZenOptics IT Services, Software Development | Other 15 Oct 2022 | |